Audit of anti-D immunoglobulin administration to pregnant Rhesus D negative women following sensitising events.
We performed a retrospective audit of 99 Rhesus D (RhD) negative women to discover if anti-D immunoglobulin (anti-D) prophylaxis was given in accordance with guidelines from the National Blood Transfusion Service Immunoglobulin Working Party (1991). It was found that all patients received appropriate management postpartum. However, more than half of the antepartum sensitising events beyond 20 weeks' gestation were not managed according to the guidelines. Only one patient was sensitised during the studied pregnancy and no sensitising events were recorded in her case. This supports the introduction of a policy of routine anti-D prophylaxis in the third trimester.
Morrison
J
J
Department of Obstetrics and Gynaecology, Stoke Mandeville Hospital, Aylesbury, UK.